Pangenomic Health Inc.
NARA
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.77% | 4.73% | 51.75% | -82.30% | -25.68% |
| Total Depreciation and Amortization | -93.55% | -95.24% | -80.43% | -56.52% | -31.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.50% | -65.70% | -89.72% | 986.71% | 859.61% |
| Change in Net Operating Assets | -75.06% | 19.45% | 71.78% | 14.11% | 6.51% |
| Cash from Operations | -3,159.57% | -353.72% | 57.78% | 86.01% | 96.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 282.98% | -51.30% | -63.34% | -94.23% | -95.13% |
| Total Debt Repaid | -- | -269.07% | -156.36% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -437.50% | -- | -- |
| Cash from Financing | 3,952.48% | 347.38% | -60.30% | -89.23% | -96.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 466.67% | 208.80% | -148.57% | -310.34% | 86.65% |